Similar localization of conformational IgE epitopes on the house dust mite allergens Der p 5 and Der p 21 despite limited IgE cross-reactivity

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 73, Issue 8, 2018, Pages 1653-1661

  Curin, M ^a   Garmatiuk, T ^a   Resch Marat, Y ^a   Chen, K W ^a   Hofer, G ^b   Fauland, K ^b   Keller, W ^b   Hemmer, W ^c   Vrtala, S ^a   Focke Tejkl, M ^a   Valenta, R ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

^c FAZ Floridsdorf Allergy Centre   (Austria)

Author keywords

allergen; allergy; cross reactivity; house dust mite allergy; IgE epitope mapping

Indexed keywords

DER P 21 ALLERGEN; DER P 5 ALLERGEN; HOUSE DUST ALLERGEN; HOUSE DUST MITE ALLERGY VACCINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; UNCLASSIFIED DRUG; VACCINE; ALLERGEN; ARTHROPOD PROTEIN; DERMATOPHAGOIDES PTERONYSSINUS ANTIGEN P 5; EPITOPE; IMMUNOGLOBULIN G; RECOMBINANT VACCINE;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBODY TITER; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CROSS REACTION; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; HOUSE DUST ALLERGY; HUMAN; IMMUNOREACTIVITY; OVERLAPPING GENE; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SURFACE PROPERTY; VACCINATION; ALPHA HELIX; ANIMAL; BLOOD; CHEMISTRY; CONFORMATION; DRUG DEVELOPMENT; IMMUNIZATION; IMMUNOLOGY; LEPORIDAE; MOLECULAR MODEL; PROTEIN FOLDING; PYROGLYPHIDAE; SYNTHESIS;

ALLERGENS; ANIMALS; ANTIGENS, DERMATOPHAGOIDES; ARTHROPOD PROTEINS; CROSS REACTIONS; DRUG DISCOVERY; EPITOPE MAPPING; EPITOPES; HUMANS; IMMUNIZATION; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; MODELS, MOLECULAR; MOLECULAR CONFORMATION; PROTEIN CONFORMATION, ALPHA-HELICAL; PROTEIN FOLDING; PYROGLYPHIDAE; RABBITS; VACCINES, SYNTHETIC;

EID: 85042181598     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13398     Document Type: Article

References (33)

1. Burbach GJ, Heinzerling LM, Edenharter G, et al. GA(2)LEN skin test study II: clinical relevance of inhalant allergen sensitizations in Europe. Allergy. 2009;64:1507-1515
2. Fernández-Caldas E, Puerta L, Caraballo L. Mites and allergy. Chem Immunol Allergy. 2014;100:234-242
3. Platts-Mills TA, Erwin EA, Heymann PW, Woodfolk JA. Pro: the evidence for a causal role of dust mites in asthma. Am J Respir Crit Care Med. 2009;180:109-113
4. Sánchez-Borges M, Fernandez-Caldas E, Thomas WR, et al. International consensus (ICON) on: clinical consequences of mite hypersensitivity, a global problem. World Allergy Organ J. 2017;10:14
5. Thomas WR. House dust mite allergens: new discoveries and relevance to the allergic patient. Curr Allergy Asthma Rep. 2016;16:69
6. Weghofer M, Thomas WR, Kronqvist M, et al. Variability of IgE reactivity profiles among European mite allergic patients. Eur J Clin Invest. 2008;38:959-965
7. Becker S, Schlederer T, Kramer MF, et al. Real-life study for the diagnosis of house dust mite allergy - the value of recombinant allergen-based IgE serology. Int Arch Allergy Immunol. 2016;170:132-137
8. Lynch NR, Thomas WR, Garcia NM, et al. Biological activity of recombinant Der p 2, Der p 5 and Der p 7 allergens of the house-dust mite Dermatophagoides pteronyssinus. Int Arch Allergy Immunol. 1997;114:59-67
9. Weghofer M, Grote M, Dall'Antonia Y, et al. Characterization of folded recombinant Der p 5, a potential diagnostic marker allergen for house dust mite allergy. Int Arch Allergy Immunol. 2008;147:101-109
10. Weghofer M, Dall'Antonia Y, Grote M, et al. Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy. 2008;63:758-767
11. Pulsawat P, Theeraapisakkun M, Nony E, et al. Characterization of the house dust mite allergen Der p 21 produced in Pichia pastoris. Protein Expr Purif. 2014;101:8-13
12. Arruda LK, Vailes LD, Platts-Mills TA, et al. Sensitization to Blomia tropicalis in patients with asthma and identification of allergen Blo t 5. Am J Respir Crit Care Med. 1997;155:343-350
13. Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139:541-549
14. Resch Y, Michel S, Kabesch M, Lupinek C, Valenta R, Vrtala S. Different IgE recognition of mite allergen components in asthmatic and nonasthmatic children. J Allergy Clin Immunol. 2015;136:1083-1091
15. Casset A, Mari A, Purohit A, et al. Varying allergen composition and content affects the in vivo allergenic activity of commercial Dermatophagoides pteronyssinus extracts. Int Arch Allergy Immunol. 2012;159:253-262
16. Hoffmann HJ, Valovirta E, Pfaar O, et al. Novel approaches and perspectives in allergen immunotherapy. Allergy. 2017;72:1022-1034
17. Bush RK. Advances in allergen immunotherapy in 2015. J Allergy Clin Immunol. 2016;138:1284-1291
18. Valenta R, Campana R, Focke-Tejkl M, Niederberger V. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 2016;137:351-357
19. Mueller GA, Gosavi RA, Krahn JM, et al. Der p 5 crystal structure provides insight into the group 5 dust mite allergens. J Biol Chem. 2010;285:25394-25401
20. Focke-Tejkl M, Campana R, Reininger R, et al. Dissection of the IgE and T-cell recognition of the major group 5 grass pollen allergen Phl p 5. J Allergy Clin Immunol. 2014;133:836-845
21. Naik MT, Chang CF, Kuo IC, et al. Roles of structure and structural dynamics in the antibody recognition of the allergen proteins: an NMR study on Blomia tropicalis major allergen. Structure. 2008;16:125-136
22. Biasini M, Bienert S, Waterhouse A, et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res. 2014;42(Web Server issue):W252-W258
23. Sanner MF, Olson AJ, Spehner JC. Reduced surface: an efficient way to compute molecular surfaces. Biopolymers. 1996;38:305-320
24. Arnon R, Van Regenmortel MH. Structural basis of antigenic specificity and design of new vaccines. FASEB J. 1992;6:3265-3274
25. Valenta R, Ferreira F, Focke-Tejkl M, et al. From allergen genes to allergy vaccines. Annu Rev Immunol. 2010;28:211-241
26. Caraballo L, Mercado D, Jiménez S, Moreno L, Puerta L, Chua KY. Analysis of the cross-reactivity between BtM and Der p 5, two group 5 recombinant allergens from Blomia tropicalis and Dermatophagoides pteronyssinus. Int Arch Allergy Immunol. 1998;117:38-45
27. Tan KW, Ong TC, Gao YF, et al. NMR structure and IgE epitopes of Blo t 21, a major dust mite allergen from Blomia tropicalis. J Biol Chem. 2012;287:34776-34785
28. Chan SL, Ong TC, Gao YF, et al. Nuclear magnetic resonance structure and IgE epitopes of Blo t 5, a major dust mite allergen. J Immunol. 2008;181:2586-2596
29. Valenta R, Campana R, Niederberger V. Recombinant allergy vaccines based on allergen-derived B cell epitopes. Immunol Lett. 2017;189:19-26
30. Focke-Tejkl M, Weber M, Niespodziana K, et al. Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy. J Allergy Clin Immunol. 2015;135:1207-7
31. Zieglmayer P, Focke-Tejkl M, Schmutz R, et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine. 2016;11:43-57
32. Cornelius C, Schöneweis K, Georgi F, et al. Immunotherapy with the preS-based grass pollen allergy vaccine BM32 induces antibody responses protecting against hepatitis B infection. EBioMedicine. 2016;11:58-67
33. Niederberger V, Neubauer A, Gevaert P, et al. Safety and efficacy of immunotherapy with the recombinant B-cell epitope-based grass pollen vaccine BM32. J Allergy Clin Immunol. 2018 Jan 11. pii: S0091-6749(17), 31884-5. https://doi.org/10.1016/j.jaci.2017.09.052. [Epub ahead of print]